A Breakthrough in APDS Treatment

This chapter highlights the groundbreaking treatment of a teenager named Mary in England, who becomes the first patient in Europe to receive a newly licensed drug for her inherited disease APDS. The narrative explores the transformative impact of this treatment on her life and family, while also discussing technological advancements at Microsoft aimed at improving user experience.